Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Pharmaceutical Research
|
February 17, 2022
Applications of Model-Based Meta-Analysis in Drug Development
Phyllis Chan, Kirill Peskov, Xuyang Song
CPT: Pharmacometrics & Systems Pharmacology
|
June 24, 2017
Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk Test
Lora Hamuro, Phyllis Chan, Giridhar Tirucherai, et al.
Cancer Chemotherapy and Pharmacology
|
July 6, 2023
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data
Nastya Kassir, Phyllis Chan, Steve Dang, et al.
The AAPS Journal
|
November 6, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric Patients
Olagoke Sule, Felix Stader, Nastya Kassir, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 25, 2023
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer
Antonio Gonçalves, Mathilde Marchand, Phyllis Chan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 6, 2020
Application of Machine Learning for Tumor Growth Inhibition - Overall Survival Modeling Platform
Phyllis Chan, Xiaofei Zhou, Nina Wang, et al.
Clinical Pharmacokinetics
|
June 20, 2016
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations
Phyllis Chan, Diane R Mould, Malaz Abu Tarif, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 13, 2017
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
Phyllis Chan, Leon Bax, Chunlin Chen, et al.
Liver Cancer
|
November 1, 2021
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic Region
Colby S Shemesh, Phyllis Chan, Hui Shao, et al.
Pharmaceutical Research
|
January 8, 2020
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected]
Phyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Pharmaceutical Research
|
February 17, 2022
Applications of Model-Based Meta-Analysis in Drug Development
Phyllis Chan, Kirill Peskov, Xuyang Song
CPT: Pharmacometrics & Systems Pharmacology
|
June 24, 2017
Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk Test
Lora Hamuro, Phyllis Chan, Giridhar Tirucherai, et al.
Cancer Chemotherapy and Pharmacology
|
July 6, 2023
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib data
Nastya Kassir, Phyllis Chan, Steve Dang, et al.
The AAPS Journal
|
November 6, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric Patients
Olagoke Sule, Felix Stader, Nastya Kassir, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
October 25, 2023
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancer
Antonio Gonçalves, Mathilde Marchand, Phyllis Chan, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
December 6, 2020
Application of Machine Learning for Tumor Growth Inhibition - Overall Survival Modeling Platform
Phyllis Chan, Xiaofei Zhou, Nina Wang, et al.
Clinical Pharmacokinetics
|
June 20, 2016
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing Recommendations
Phyllis Chan, Diane R Mould, Malaz Abu Tarif, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
July 13, 2017
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary Fibrosis
Phyllis Chan, Leon Bax, Chunlin Chen, et al.
Liver Cancer
|
November 1, 2021
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic Region
Colby S Shemesh, Phyllis Chan, Hui Shao, et al.
Pharmaceutical Research
|
January 8, 2020
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected]
Phyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Page
of 4